F/M Investments’s Collegium Pharmaceutical COLL Stock Holding History

F/M Investments’s Portfolio COLL Stock Details COLL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-47,993	Closed	-$1.59M	–	361
2026 Q1	$1.59M	Sell	47,993 -2,056	-4%	-$87K	0.11%	122
2025 Q4	$2.32M	Sell	50,049 -3,991	-7%	-$167K	0.09%	216
2025 Q3	$1.89M	Sell	54,040 -24,685	-31%	-$858K	0.07%	249
2025 Q2	$2.33M	Buy	78,725 +1,049	+1%	+$29.9K	0.08%	217
2025 Q1	$2.32M	Buy	77,676 +4,513	+6%	+$138K	0.09%	213
2024 Q4	$2.1M	Buy	+73,163	New	+$2.42M	0.08%	224

Other funds holding COLL

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Jupiter Topco New York $245B AUM

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return

F/M Investments's COLL Position: Q2 2026 in Review

F/M Investments sold out of Collegium Pharmaceutical (COLL) in Q2 2026, closing a stake of 47,993 shares — an estimated $1.59M sold.

F/M Investments first reported a position in COLL in Q4 2024 and held it in 6 quarters. The position peaked at $2.33M in Q2 2025. 280 funds tracked by Wall St. Rank hold COLL as of Q2 2026.

F/M Investments reported no remaining Collegium Pharmaceutical position as of Q2 2026 after selling out during the quarter.
F/M Investments sold 47,993 Collegium Pharmaceutical shares in Q2 2026, an estimated $1.59M.
F/M Investments first reported a position in Collegium Pharmaceutical in Q4 2024 and held it in 6 quarters.
F/M Investments's Collegium Pharmaceutical position peaked at $2.33M in Q2 2025.
280 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q2 2026.

Based on F/M Investments's 13F filing for Q2 2026, filed 5 Aug 2026.